A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies.

Posey, J A

A pilot trial of GM-CSF and MDX-H210 in patients with erbB-2-positive advanced malignancies. [electronic resource] - Journal of immunotherapy (Hagerstown, Md. : 1997) Jul 1999 - 371-9 p. digital

Publication Type: Clinical Trial; Journal Article

1524-9557

10.1097/00002371-199907000-00011 doi


Adenocarcinoma--drug therapy
Adolescent
Adult
Aged
Antibodies, Bispecific--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antibody Formation--drug effects
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cytokines--drug effects
Disease-Free Survival
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Granulocyte-Macrophage Colony-Stimulating Factor--administration & dosage
Humans
Injections, Subcutaneous
Leukocyte Count--drug effects
Male
Middle Aged
Pilot Projects
Receptor, ErbB-2--blood
Severity of Illness Index
Survival Rate
Treatment Outcome